Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 85c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Join SI Premium – FREE
Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of $, $0.85 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Douglas Dynamics (PLOW) Tops Q3 EPS by 6c; updates guidance
- California Resources (CRC) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
